Therefore, this immunohistochemical study explores cathepsin B, L, and S expression levels in a large breast cancer patient cohort, to investigate in which breast cancer patients the use of cathepsin-targeted NIR FI may have added value. This evidence concerns the gene CTSS and breast cancer.